A5028475920- Acute Lymphoblastic Leukemia research
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Public Health in Brazil
- Prenatal Screening and Diagnostics
- Ethics in Clinical Research
- Health, Nursing, Elderly Care
- Neutropenia and Cancer Infections
- Environmental Sustainability and Education
- Organ Donation and Transplantation
- Advanced Data Storage Technologies
- Cardiac Arrhythmias and Treatments
- Chronic Lymphocytic Leukemia Research
- Artificial Intelligence in Healthcare
- Hematological disorders and diagnostics
- Machine Learning in Healthcare
- Maternal and Neonatal Healthcare
- Cardiac pacing and defibrillation studies
- Big Data and Business Intelligence
- Global Cancer Incidence and Screening
- Mosquito-borne diseases and control
- Advanced Database Systems and Queries
- Healthcare Systems and Reforms
- Renal Transplantation Outcomes and Treatments
- Attention Deficit Hyperactivity Disorder
Brazilian Medical Association
2022-2024
Hospital Moinhos de Vento
2024
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2023
Hospital de Clínicas Universidade Federal do Paraná
2023
São Camilo Hospital
2020
The development of the Brazilian Registry Hematopoietic Cell Transplantation in collaboration with Center for International Blood and Marrow Transplant Research (CIBMTR) allowed an assessment activity general outcomes transplants Brazil. Here, we report updated activity. transplant centers their data to CIBMTR, using FormsNet3 platform. Information returns Cellular Therapy Bone Society (SBTMO) through Data Back Centers (DBtC) tool. from patients who received HCT 2012 2023 were extracted...
The first hematopoietic stem cell transplantation (HSCT) program in Latin America started 1979 at the federal university hospital Curitiba, Paraná, Brazil. Over years, number of centers performing transplants our country has increased tremendously, generating need to know results this treatment modality. Understanding HSCT scenario Brazil is still challenging, since not all Brazilian report data Center for International Blood and Marrow Research (CIBMTR). Despite improvement reporting over...
The first HSCT program in Latin America started 1979 at the Federal University Hospital (Curitiba, Paraná). Over years, number of centers performing transplants country increased, generating need to know results this modality treatment. Understanding scenario Brazil is still challenging since not all Brazilian report data Center for International Blood and Marrow Research (CIBMTR). Although it has been improving over last infrastructure trained managers are lacking. partnership between...
To increase the report of Brazilian hematopoietic stem cell transplantation (HSCT) data to Center for International Blood and Marrow Transplant Research (CIBMTR), Data Managers Working Group (GTGD) Society Bone Transplants (SBTMO), Sao Paulo State Association (AMEO) developed several strategies since 2016: training managers (GDs) in national international HSCT meetings, development a free online teaching course (EAD) Portuguese on Essential (TED), online presential new offered by AMEO,...
Since the first hematopoietic stem cell transplantation (HSCT) was performed at Federal University Hospital (Curitiba, PR) in 1979, number of centers offering this modality treatment has increased. However, accessing comprehensive HSCT outcomes become a challenge due to lack an official Brazilian registry. The partnership between Cellular Therapy and Bone Marrow Transplant Society (SBTMO) Center for International Blood Research (CIBMTR) important milestone establishment registry (HSCTBR). By...
Understanding the HSCT scenario in Brazil is challenging due to lack of a national registry that allows analysis results. The partnership between Brazilian Cellular Therapy and Bone Marrow Transplant Society (SBTMO) Center for International Blood Research (CIBMTR) allowed return data registered CIBMTR, through Data Back (DBtC), standardized organized way. With this database it was possible know demographic outcomes transplants performed Brazil. spreadsheet imported into Power BI desktop,...
IntroductionThe Center for International Blood & Marrow Transplant Research (CIBMTR) presents a system that makes it easier to register standardized transplantation data, as well business intelligence tool the devolution of data transplant centers, Qlikview app, which allows extraction. The software might be useful conduction clinical trials.ObjectiveTo evaluate overall survival (OS) and characteristics patients (pts) undergoing hematopoietic stem cell (HSCT) in Brazil while testing...
Hematopoietic stem cell transplantation (HSCT) has been used to treat many malignant and nonmalignant hematologic conditions; however, the use of HSCT in patients who refuse blood transfusions rarely described literature, no data have published concerning haploidentical without products. The aim this study is describe experience a Brazilian group performing 21 HSCTs components first 100 days after transplantation, which period corresponding greatest risk toxicity for procedure. We developed...
To better understand the outcomes of HSCT in Brazil, we conducted a multicenter study using CIBMTR database. Seven participating centers extracted their own data through Data Back to Center tool. Main indications for HSCT-auto were MM(51%), NHL(18%) and HL(17%); Allogeneic, AML(24%), ALL(23%) SAA(15%). For acute leukemias, risk death was higher 18-40 years group (HR=1.18,p=0.022), 40-60(HR=1.19,p<0.001) 60+(HR=1.39,p=0.007), compared with 0-18 years, ALL (HR=1.05,p <0.001, AML)...
The number of hematopoietic stem cell transplantation (HSCT) in Brazil is growing rapidly. To better understand the outcomes HSCT Brazil, strategies have been developed with Center for International Blood and Marrow Transplant Research (CIBMTR), using its standardized registry structure data sharing application. methods adopted to establish were through efforts increase Brazilian centers that report CIBMTR included training courses managers, officialization a multicenter study partnership...
Introduction Although there are 70 TCs in Brazil, the HCT data reporting (DR) for a local database has not been made feasible yet; beyond that, number of Brazilian any international research (IRD) is still small. Reporting an IRD generates scientific information, enabling medical professionals to understand and analyze results among worldwide. This TC performed 670 HCTs (autologous allogeneic) along 13 years. In January 2017, we started submit CIBMTR (Center International Blood & Marrow...
IntroductionMany developing countries do not have a consolidated registry to report hematopoietic stem cell transplant outcomes (HSCT), what poses great challenge understand the HSCT results. The CIBMTR is an excellent strategy for these report, validate, and their own nationwide data.ObjectiveTo strategies tools developed in Brazil increase number of active centers reporting data CIBMTR.MethodsThe Brazilian Society Bone Marrow Transplant (SBTMO) Sao Paulo State Association (AMEO),...